-
Whose home is the first imitation of flowers in China? 21 pharmaceutical companies compete for two global heavyweight products
Time of Update: 2017-10-31
In recent days, Hyundai pharmaceutical has issued two successive announcements, saying that the company and its wholly-owned subsidiary Shanghai Hyundai pharmaceutical Haimen Co., Ltd have received th
-
This pharmaceutical company is powerful! Last year's huge loss was nearly 400 million, and this year's loss turned into profit
Time of Update: 2017-10-29
Recently, Shuangcheng Pharmaceutical Co., Ltd disclosed the third quarter report of 2017 The report shows that the performance of the first three quarters of this year is still in the state of loss It
-
Recent domestic listing of new drugs (degu insulin, etc.)
Time of Update: 2017-10-26
1 On October 19, 2017, China's State Food and Drug Administration (CFDA) approved the new drug registration application of "recombinant Ebola virus vaccine (adenovirus vector)" The vaccine is an innov
-
Count the innovative drugs that have entered the fast lane for review and approval
Time of Update: 2017-10-24
In 2017 (as of September 30), CDE undertook a total of 3509 drug registration applications (calculated by acceptance number, the same below), an increase of 447 compared with the same period last year
-
The first recombinant Ebola virus vaccine was approved at an advanced speed
Time of Update: 2017-10-22
On October 19, 2017, the State Food and Drug Administration approved the new drug registration application of "recombinant Ebola virus vaccine (adenovirus vector)" Source | CFDA this vaccine is an inn
-
Two highlights of "Glassman" drug market: China's huge growth potential and a large number of breakthrough and heavy new drug reserves
Time of Update: 2017-10-22
In our life, there is a group of people who may accidentally bleed with a small scratch, suffer from joint pain or even necrosis due to a wrestling, and have gastrointestinal bleeding or urination wit
-
28 kinds of accelerated approval of children's drugs have been included in the priority review
Time of Update: 2017-10-20
The concept of using children's medicine for children's illness is being recognized by more parents, but many parents find that the commonly used medicine often has no dosage form for children, and ch
-
Children anorexia Chinese patent medicine market situation mutation, more than 100 million varieties who?
Time of Update: 2017-10-19
At present, the scale of children's drug market accounts for about 5.0% of the total scale of the national drug market, but the market is far from saturated, of which about 80% are Chinese patent medi
-
Traditional Chinese medicine injection is on the cusp of the storm. Who can top 10 products last?
Time of Update: 2017-10-19
On the last day of the long National Day holiday, the document "opinions on deepening the reform of the review and approval system and encouraging the innovation of pharmaceutical and medical devices"
-
The main force of domestic enterprises has been rising for four years in a row. How to digest the market?
Time of Update: 2017-10-19
According to Zhongkang CMH data, the sales volume in 2017 is expected to reach 247.4 billion yuan Who are the top 10 varieties? According to the data monitoring of Zhongkang CMH, digestive system and
-
The top 10 analgesic varieties account for over 80% of public hospitals in key cities, and the champion is
Time of Update: 2017-10-11
Wonderful content October 11, 2017 is the fourteenth "world analgesia day", and "safe medication, green analgesia" is another new theme With the development of society, chronic pain has been paid more
-
New anti hepatitis C drugs are on the market in China, interferon has become the future
Time of Update: 2017-10-10
In April last year, the drug evaluation center (CDE) of the State Food and Drug Administration announced that 10 new anti hepatitis C drugs from 7 enterprises were included in the priority evaluation
-
Neglected cancer pain drugs: huge market potential, insufficient investment in drug research and development
Time of Update: 2017-10-09
At present, the market of cancer pain treatment drugs is still a small market, but the increasing number of cancer pain patients will drive the continuous growth of the market demand for pain manageme
-
In depth analysis of the market pattern of psoriasis in China in 2016
Time of Update: 2017-09-28
Psoriasis is a kind of hereditary chronic skin inflammation, which belongs to autoimmune chronic skin disease The global number of patients is about 125 million So far, psoriasis can not be cured, oft
-
The domestic vaccine market will rise, whose family will the next heavyweight variety spend?
Time of Update: 2017-09-28
As the largest vaccine industry country in the world, China's vaccine industry has made great achievements in development, but it is not a strong country in terms of output value and industrial techno
-
Accelerate the approval of imported drugs and list the domestic new drugs to be approved for marketing
Time of Update: 2017-09-27
Last week, CDE concentrated on the approval of imported drugs Gilead's new oral hepatitis C drugs, sophibuvir tablets, ibuprofen's obipalin tablets, dasebovir tablets, bringer Ingelheim's englejin tab
-
TOP 20 accounts for over 75%! Take a closer look at the leading products in the hundreds of billions of cardiovascular and cerebrovascular drugs market
Time of Update: 2017-09-26
September 24 is world heart day The eternal theme of world heart day is "healthy heart, happy life" As we all know, the heart is the only organ that can't rest for a moment Coronary heart disease, arr
-
Who will dominate the market of hepatitis C drugs in China
Time of Update: 2017-09-26
On September 21, 2017, the combination therapy of direct antiviral drug for hepatitis C (DAAS) sovaldi (jxhs1700011) and similar drug for Albuquer (jxhs1700014) dasabuvir (jxhs1700015) was approved fo
-
Stunned! The gross profit margin of these 8 pharmaceutical companies is over 90%. What are they selling?
Time of Update: 2017-09-25
In recent years, A-share pharmaceutical companies are hot in the capital market, and their development speed is amazing In the first half of this year, there are 8 listed pharmaceutical companies with
-
Nearly 10 billion inhalation preparations market has been divided by these five enterprises
Time of Update: 2017-09-22
According to the test data of Zhongkang CMH data, the scale of respiratory system drug use in China reached 137.2 billion yuan, of which the market of inhalation preparations is on the rise In 2016, t
